Maze Therapeutics
PublicLast Round
Private Placement
Sep 11, 2025
Total Funding Raised
$944.3M
Company Overview
Maze Therapeutics is a biotechnology company that specializes in translating genetic insights into innovative medicines by leveraging large-scale human genetics data, functional genomics, and diverse drug discovery methods to identify modifier genes and enhance target biology understanding for novel therapy development.
Sector
Biotech
AI Layer
Application
Keywords
small molecule precision medicinesdrug discovery for genetically defined diseasesgenetic target identification and validationhuman genetics and functional genomics platformbiopharma out-licensing and partnershipsAPOL1 inhibitor for kidney diseaseGYS1 inhibitor for Pompe diseasedata science-driven drug discoverygene therapy for amyotrophic lateral sclerosis (ALS)SLC6A19 inhibitor for chronic kidney diseaseclinical-stage biopharmaceutical companytherapeutics for renal and metabolic diseases
Maze Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Maze Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Sep 11, 2025 | ||||
| IPO Announced | Jan 30, 2025 | ||||
| Series D | Dec 3, 2024 | ||||
| Series C | Jan 10, 2022 | ||||
| Series B | Feb 1, 2021 | ||||
VC Round | Oct 23, 2019 |
Maze Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series D, Series B, Series C |
| Janus Henderson Group | Series D, Private Placement |
| TCG Crossover | Private Placement |
| GV | Series D, Series B, Series A |
| Guggenheim Securities | IPO |
| Deep Track Capital | Private Placement, Series D |
| Hill City Capital | Series C, VC Round |
Maze Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersSouth San Francisco, California
Employee Range157
Year Founded2018
Last FundingSep 11, 2025